IBRO-UCT African Advanced School on Neuropsychiatric Genomics

 

Applications open for IBRO-UCT African Advanced School on Neuropsychiatric Genomics

IBRO-UCT African Advanced School on Neuropsychiatric Genomics

Cape Town, South Africa

December 1 – 14, 2016

Organizer: Dr. Shareefa Dalvie and Professor Dan Stein (University of Cape Town)

Aims and Scope of the School:

The aims of this school are to provide advanced research training in clinical and analytical aspects of neuropsychiatric genomics.

Description:

There have been remarkable advances in large-scale genomic technology and analysis methods over the last few years. With the use of thousands of case and control samples, genome-wide association studies (GWAS), which measure common genetic variation across the genome, have been able to identify possible candidate loci for various neuropsychiatric disorders. In addition, next-generation sequencing (NGS) technologies have had considerable success in identifying rare variation for complex disorders. The purpose of this school is to bring students from around Africa for intensive two week training, which will include lectures and practical sessions on the ethics, project design, logistical considerations, and statistical analysis of large scale genomic studies of neuropsychiatric disorders. In addition, practical training will be provided on the open-source resources from the Allen Institute for Brain Science.

Who should apply to this School?

Applications are open to PhD students, post-doctoral fellows, registrars, & junior faculty engaged in clinical and/or basic research pertaining to neuropsychiatric genomics and who are currently residing in Africa.

What costs will be covered for selected applicants?

Accommodation and meals will be provided. Assistance with travel expenses to South Africa will be available if required and adequately motivated.

Application deadline: July 10, 2016 (11:59 p.m. CET)

Apply here

For all enquiries, please contact Dr. Shareefa Dalvie at dlvsha006@myuct.ac.za

Co-sponsors:

Stanley Center for Psychiatric Research and the Allen Institute for Brain Science

Leave a Reply